Lidocaine Hydrochloride Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, stabilizing them in an inactive state. This prevents sodium influx, which is essential for the generation and propagation of nerve impulses, thereby producing a reversible loss of sensation in the area where it is administered.

The specific dose of Lidocaine Hydrochloride Noridem is determined by the prescribing clinician based on the procedure, route of administration, patient weight, and clinical condition. Only a qualified healthcare professional should set the dosage and administration schedule.

Safety data for lidocaine use in pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician after a thorough risk‑benefit assessment.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Lidocaine is a medium‑duration amide‑type local anesthetic with a rapid onset of action. Compared with agents such as bupivacaine, lidocaine has a shorter duration but a lower risk of cardiotoxicity at therapeutic doses, making it suitable for procedures requiring quick recovery of sensation.

Lidocaine Hydrochloride Noridem should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from light, moisture and extreme temperatures. Do not freeze the product, and discard any vial that appears cloudy or contains particles.

The medication is supplied as a sterile injectable solution and is administered by a qualified healthcare professional via epidural, intradermal or intramuscular injection, depending on the clinical indication and the desired area of anesthesia.

Serious risks include systemic toxicity leading to central nervous system symptoms such as seizures, cardiac arrhythmias or arrest, severe allergic reactions (anaphylaxis), methemoglobinemia, and profound hypotension. Immediate medical attention is required if any of these events occur.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block, uncontrolled cardiac conduction disorders, or those taking medications that significantly raise lidocaine plasma levels should avoid using this product unless specifically directed by a physician.